Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Prev Med. 2014 Oct;47(4):505-7. doi: 10.1016/j.amepre.2014.06.022. Epub 2014 Aug 3.

Harm reduction at the crossroads: the case of e-cigarettes.

Author information

1
Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida; and Syrian Center for Tobacco Studies, Aleppo, Syria. Electronic address: wmaziak@fiu.edu.

Abstract

The recent popularity of electronic (e)-cigarettes and their rapid uptake by youth has ignited the debate about their role as a harm-reduction strategy. Harm reduction in the context of tobacco control contends that in societies that have achieved considerable success in curbing smoking, leaving the remaining hard-to-quit smokers with an abstinence-only option is unfair, especially when less-harmful choices are available. On one side of the debate are those who call for caution in endorsing such products until critical pieces of evidence about their safety and potential become available, whereas the other side argues that waiting until all questions about e-cigarettes are answered is dogma driven. In this piece, I try to discuss the unresolvable contention between harm-reduction goals of offering safer options to smokers, and those of e-cigarette makers of being commercially viable and profitable.

PMID:
25092121
PMCID:
PMC4171135
DOI:
10.1016/j.amepre.2014.06.022
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center